Advertisement
Letter to the Editor| Volume 85, ISSUE 6, P611, June 2012

Update on and correction to the cost-effectiveness of contraceptives in the United States

      In Fig. 2, we update our results on the cost-effectiveness of contraceptives in the United States [
      • Trussell J.
      • Lalla A.M.
      • Doan Q.V.
      • Reyes E.
      • Pinto L.
      • Gricar J.
      Cost-effectiveness of contraceptives in the United States.
      ] to reflect recent increases in the average wholesale price (AWP) of the Mirena IUS to $844 (an increase of 44% over the AWP of $586 in the original paper), of the ParaGard IUD to $718 (an increase of 45% over the AWP of $494 in the original paper), of the Implanon implant to $791 (an increase of 26% over the AWP of $627 in the original paper) and of the injectable Depo-Provera to $102 (an increase of 34% over the AWP of $76 in the original paper). The results for Implanon are the same for its replacement Nexplanon. We also correct an error in the annualized cost of the Mirena IUS in years 1���4 in previous corrections and updates; we are grateful to Anna Filonenko for pointing out this error. We note that calculated benchmark price has replaced AWP as the new pricing term but is calculated the same way.
      Figure thumbnail gr1
      Fig. 2Annualized costs associated with contraceptive methods. Note: the annualized cost at year x is the total cost for x years divided by x. OCs, oral contraceptives; TL, tubal ligation; Inj, Depo-Provera; IUS, Mirena IUS; Imp, Implanon/Nexplanon; MC, male condom; Vas, vasectomy; IUD, ParaGard intrauterine device. The annualized costs for tubal ligation for years 1 and 2 (not shown in graph) were $2912 and $1470, respectively.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      Reference

        • Trussell J.
        • Lalla A.M.
        • Doan Q.V.
        • Reyes E.
        • Pinto L.
        • Gricar J.
        Cost-effectiveness of contraceptives in the United States.
        Contraception. 2009; 79 ([Erratum. Contraception 2009;80:229-30. Update. Contraception 2010;82:391. Update and correction, Contraception 2012;85:218]): 5-14